3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
109
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
9
Lymphoma
3
Carcinoma, Hepatocellular
3
Cardiotoxicity
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Pseudomyxoma Peritonei
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurotoxicity Syndromes
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Fatigue
1
Fallopian Tube Neoplasms
1
Desmoid Tumors
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Breast Cancer Organoids
1
Brain Neoplasms
1
Interventions
Psychiatric Rehabilitation
7
Flow Cytometry
6
Therapeutics
5
Surveys and Questionnaires
5
Microarray Analysis
5
Gene Expression Profiling
5
Vincristine
4
Polymerase Chain Reaction
4
Methotrexate
4
Daunorubicin
4
Cytogenetic Analysis
4
Amplified Fragment Length Polymorphism Analysis
4
ponatinib
3
fludarabine
3
Watchful Waiting
3
Prednisone
3
Observation
3
Mercaptopurine
3
Interviews as Topic
3
Inotuzumab Ozogamicin
3
Immunologic Techniques
3
Immunoenzyme Techniques
3
Cytarabine
3
Cyclophosphamide
3
tisagenlecleucel
2
pegaspargase
2
fish oil triglycerides
2
blinatumomab
2
In Situ Hybridization, Fluorescence
2
Imatinib Mesylate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Doxorubicin
×
Clear all
NCT05959720
2025-05-07
BRALLA
Instituto do Cancer do Estado de São Paulo
Recruiting
180 enrolled